The role of Hepatitis B E Antigen status in the natural history and therapeutic outcomes of chronic Hepatitis B

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Hepatitis B can cause liver failure and cancer and affects between 90,000 and 160,000 people in Australia. Effective treatments are available but these cannot eradicate the virus. We will study the natural history to try and identify reasons why some people develop severe liver disease and others do not and why some patients respond to treatment and others do not. We will also look at of the best ways to monitor patients with blood tests whether they are receiving treatment or not.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2010

Funding Scheme: NHMRC Postgraduate Scholarships

Funding Amount: $88,342.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

hepatic fibrosis | hepatitis B | liver cancer